Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ephedrine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104805148A details a novel enzymatic route for (1R,2S)-N-pyrrolidyl norephedrine. This method eliminates controlled precursors, offering significant cost and supply chain advantages for API manufacturers.
Novel resolution method for optically pure ephedrine using L-(-)-dibenzoyltartaric acid. High yield, recoverable agent, scalable industrial process.
Patent CN101570492B details a high-yield ephedrine synthesis route reducing solvent use and environmental impact for scalable pharmaceutical manufacturing supply chains.
Patent CN1197447A discloses a robust method for resolving racemates like selegiline and ephedrine using stable phenoxypropionic acid derivatives, offering high purity and scalable manufacturing advantages.
Analysis of patent CN1282746C reveals a microbial route for high-purity beta-amino alcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN114150009A reveals a novel enzymatic route for ephedrine using engineered E. coli and yeast, offering high yield and environmental compliance for pharma supply chains.
High-yield imine reductase method for ephedrine production offers supply chain stability and cost efficiency for pharmaceutical intermediates.